Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunotherapy in bronchial carcinoma].

K Havemann

    Onkologie
    |June 1, 1980
    PubMed
    Summary

    Nonspecific immune stimulation in early bronchogenic carcinoma may delay relapse but doesn't clearly increase cure rates. Alternative immunotherapy strategies, like manipulating humoral immunity, are needed for better outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A novel small-cell lung carcinoma-specific DNA-binding activity related to the transcription factor ap-1.

    International journal of oncology·2011
    Same author

    Transdifferentiation, a Potential Mechanism for Covering Vascular Grafts Grown Within Recipient's Peritoneal Cavity With Endothelial-Like Cells.

    Circulation research·2002
    Same author

    Exposure to armament wastes and leukemia: a case-control study within a cluster of AML and CML in Germany.

    Leukemia research·2001
    Same author

    Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells.

    European journal of cell biology·2001
    Same author

    Endothelial-like cells derived from human CD14 positive monocytes.

    Differentiation; research in biological diversity·2000
    Same author

    Non-Hodgkin's lymphoma protocols in the treatment of patients with Burkitt's lymphoma and lymphoblastic lymphoma: a report on 58 patients.

    Leukemia & lymphoma·1999

    Area of Science:

    • Oncology
    • Immunology
    • Cancer Research

    Context:

    • Bronchogenic carcinoma treatment
    • Adjuvant therapy in early-stage lung cancer
    • Tumor immunotherapy clinical trials

    Purpose:

    • To evaluate the efficacy of nonspecific immune stimulation in bronchogenic carcinoma.
    • To explore alternative immunotherapy strategies for lung cancer.

    Summary:

    • Clinical trials using nonspecific immune stimulation (systemic or local) in early bronchogenic carcinoma suggest a potential delay in relapse time.
    • Studies with tumor antigen preparations may yield similar effects on relapse.
    • The impact on cure rates remains uncertain, prompting consideration of alternative approaches.
    • Research in small cell bronchogenic carcinoma indicates that manipulating humoral immunity, such as influencing circulating immune complexes, could be a viable therapeutic concept.

    Impact:

    • Highlights the limitations of current nonspecific immunotherapy for lung cancer.
    • Suggests a need for novel therapeutic strategies in tumor immunotherapy.
    • Identifies manipulation of humoral immunity as a potential future direction for treating small cell bronchogenic carcinoma.

    Related Experiment Videos